| |
| |
|
| Insider
Information: |
Soffer Gad |
| Relationship: |
EVP & Chief Strategy O... |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
243,966 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$168,337 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
243,966 |
|
|
| Total
Value |
$168,337 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
EVP & Chief Strategy O... |
2018-09-22 |
243,966 |
2015-01-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2018-09-22 |
4 |
D |
$39.85 |
$882,996 |
D/D |
(22,158) |
243,966 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2018-08-15 |
4 |
D |
$35.90 |
$13,714 |
D/D |
(382) |
266,124 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2018-05-15 |
4 |
D |
$45.90 |
$17,534 |
D/D |
(382) |
266,506 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2018-02-15 |
4 |
D |
$47.05 |
$68,505 |
D/D |
(1,456) |
266,888 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2018-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,764 |
268,344 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2018-02-09 |
4 |
D |
$41.70 |
$173,847 |
D/D |
(4,169) |
265,580 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2018-02-06 |
4 |
D |
$35.80 |
$142,735 |
D/D |
(3,987) |
269,749 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
273,736 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-11-17 |
4 |
AS |
$15.00 |
$105,000 |
D/D |
(7,000) |
256,236 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,146 |
263,236 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-08-16 |
4 |
AS |
$14.53 |
$35,802 |
D/D |
(2,464) |
259,090 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,145 |
261,554 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-08-15 |
4 |
AS |
$15.00 |
$105,000 |
D/D |
(7,000) |
257,409 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-05-16 |
4 |
AS |
$15.19 |
$86,188 |
D/D |
(5,674) |
264,409 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-05-15 |
4 |
AS |
$15.13 |
$105,910 |
D/D |
(7,000) |
259,527 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,556 |
270,083 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-03-10 |
4 |
AS |
$20.00 |
$50,000 |
D/D |
(2,500) |
266,527 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-02-16 |
4 |
AS |
$15.62 |
$113,604 |
D/D |
(7,273) |
269,027 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,762 |
276,300 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-02-14 |
4 |
AS |
$15.22 |
$106,540 |
D/D |
(7,000) |
262,538 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-02-10 |
4 |
AS |
$15.42 |
$97,029 |
D/D |
(6,274) |
269,538 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Strategy Officer |
• – – |
2017-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
275,812 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2016-11-17 |
4 |
AS |
$18.41 |
$27,247 |
D/D |
(1,480) |
230,812 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2016-11-16 |
4 |
AS |
$19.27 |
$137,511 |
D/D |
(7,136) |
232,292 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Operating Officer |
• – – |
2016-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,761 |
239,428 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
